drugset / Trial / NCT05883241

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture

NCT05883241

Phase 1 Recruiting 90 enrolled ZetrOZ, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the ability of long-duration low-intensity therapeutic ultrasound (LITUS) to alleviate bone-fracture related pain over a 12-week period. The primary objective of this study is to evaluate the analgesic effect of LITUS in subjects suffering from bone-fracture pain. Secondary objectives are to assess the ability of LITUS to improve patients return to work time.

Timeline

Start
2023-06-01
Primary completion
2026-02-01
Completion
2026-02-28

Drugs

EvaluationDrugModalityDoseRoute
Background Diclofenac Other / unclassified 2.5 % Topical